Fundraising Fox
/People
Sign in

Michele Stone

Chief Scientific Officer at Kriya Therapeutics

Apex, North Carolina, United States

Find your path to Michele

30 people in our graph can introduce you to Michele.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Eric Floyd to introduce you to Michele

You →Eric · together at Axovant Sciences (2018) →Michele

Ask Jamie Chen to introduce you to Michele

You →Jamie · together at Axovant Sciences →Michele

Ask Sam Okafor to introduce you to Michele

You →Sam · 7 people · together at Kriya Therapeutics →Michele

Sign up to find every way you can get introduced to Michele

  • Your email: the people you already email who know Michele
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Michele
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Chief Scientific Officer at Kriya Therapeutics

Intro paths

→

In turn, Michele can intro founders to Kriya Therapeutics's investors below.

Kriya Therapeutics's investors · 10

Alumni VenturesManchester · $100K – $10M checks · since 2025Amplo VenturesHouston · since 2021AnjostOxford · since 2021Bluebird VenturesPalo Alto · since 2021Foresite CapitalWest Hollywood · since 2021Holland CapitalAmsterdam · since 2021JDRF T1D FundBoston · since 2021Narya CapitalColumbus · since 2021Patient Square CapitalMenlo Park · since 2021Premji InvestMenlo Park · since 2021

Co-founders at Kriya Therapeutics

RJRoger Jeffs
Roger JeffsCo-Founder and Vice Chairman
FWFraser Wright
Fraser WrightScientific Co-Founder and Chief Gene Therapy Officer
SRShankar Ramaswamy
Shankar RamaswamyFounder

Experience

  1. Kriya TherapeuticsChief Scientific Officercurrent2022 — presentUnited States
  2. Kriya TherapeuticsSenior Vice President Research and Development2020 — 2022Raleigh-Durham-Chapel Hill Area
  3. Maono Consulting LLCPresident, Senior Consultantcurrent2018 — presentRaleigh-Durham, North Carolina Area
  4. Axovant Gene Therapies, LtdVice President, Early Development2019 — 2020RTP North Carolina
  5. Axovant SciencesSenior Director, Head Nonclincal2018 — 2019Raleigh-Durham, North Carolina Area
  6. Liquidia TechnologiesExecutive Director Vaccines2015 — 2018RTP, NC
  7. Liquidia TechnologiesDirector Vaccines2012 — 2014RTP NC
  8. AerasDirector2008 — 2012
  9. Canon U.S. Life SciencesSenior Scientist2005 — 2008
  10. Aeras Global TB Vaccine FoundationScientist2004 — 2005Rockville, MD
  11. University of MarylandPost Doc2001 — 2004

Skills & more

VaccinesBiotechnologyCell CultureImmunologyMolecular BiologyLifesciencesCellMicrobiologyBiochemistryPCRProtein ChemistryCell Biology
+12 moreAssay DevelopmentImmunoassaysELISAScienceVirologyPurificationGenomicsRT-PCRLaboratoryAnalytical ChemistryqPCRDNA

From Michele's professional profile.

Frequently asked questions

Who is Michele Stone?
Chief Scientific Officer at Kriya Therapeutics
Where does Michele Stone work?
Michele Stone is Chief Scientific Officer at Kriya Therapeutics.
Where did Michele Stone go to school?
Michele Stone studied at University of Maryland Baltimore (Doctor of Philosophy - PhD, Biochemistry and Molecular Biology); University of Lynchburg (BS, chemistry); Central Virginia Community College (AAAS, Science).

Same school

Shared employers